DOCSLIB.ORG

Ranoside, Actinofu- Ranone C and Further New Bioactive Secondary Metabolites from Terrestrial Streptomyces Spp

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ranoside, Actinofu- Ranone C and Further New Bioactive Secondary Metabolites from Terrestrial Streptomyces Spp Humaira Naureen ___________________________________________________ Dehydrorabelomycin-1-O--L-rhamnopyranoside, Actinofu- ranone C and Further New Bioactive Secondary Metabolites from Terrestrial Streptomyces spp. OH O O CH CH OH H N 3 3 O CH 2 OH O 3 O H3C OH OH O OH CH3 HO O OH OH OH O CH3 CH3 CH3 CH3 OH O HO O HO HO Dissertation Dehydrorabelomycin-1-O--L-rhamnopyranoside, Actinofuranone C and Further New Bioactive Secondary Metabolites from Terrestrial Streptomyces spp. Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultäten der Georg-August-Universität zu Göttingen vorgelegt von Humaira Naureen aus Chakwal (Pakistan) Göttingen 2011 D7 Referent: Prof. Dr. H. Laatsch Korreferent: Prof. Dr. U. Diederichsen Tag der mündlichen Prüfung: 15-07-2011 Die vorliegende Arbeit wurde in der Zeit von Oktober 2007 bis Juni 2011 im Institut für Organische Chemie der Georg-August-Universität zu Göttingen unter der Leitung von Herrn Prof. Dr. H. Laatsch angefertigt. Herrn Prof. Dr. H. Laatsch danke ich für die Möglichkeit zur Durchführung dieser Arbeit sowie die ständige Bereitschaft, auftretende Probleme zu diskutieren. For my parents and my husband Contents I Table of Contents 1 Introduction .............................................................................................. 1 1.1 Importance of natural products in drug discovery ..................................... 1 1.2 Recently isolated metabolites from Streptomyces spp. .............................. 4 2 Objectives of the present research work .............................................. 16 3 General techniques ................................................................................. 18 3.1 Collection of strains ................................................................................. 18 3.2 Working up procedure of selected bacterial strains ................................. 18 3.3 Pre-screening ............................................................................................ 20 3.4 Chemical screening .................................................................................. 20 3.5 Biological and pharmacological screening .............................................. 21 3.6 Cultivation and scale up ........................................................................... 22 3.7 Isolation methods ..................................................................................... 23 3.8 Dereplication ............................................................................................ 23 4 Investigation of the selected bacterial strains ...................................... 25 4.1 Terrestrial Streptomyces sp. GW54/453 .................................................. 25 4.1.1 (2E,6E)-5-Hydroxy-4,6-dimethyl-octa-2,6-dienoic acid ......................... 26 4.1.2 Actinofuranone C ..................................................................................... 31 4.1.3 4-Acetyl-1,3-dihydro-imidazo[4,5-b]pyridin-2-one ................................ 36 4.1.4 2,5-Furan-dimethanol ............................................................................... 38 4.2 Terrestrial Streptomyces sp. Ank 245 ...................................................... 38 4.2.1 1,6-Dihydroxy-2-methyl-heptan-4-one .................................................... 40 4.2.2 4-Hydroxy-1-(2-methyl-oxiranyl)-pentan-2-one ..................................... 42 4.2.3 2-(2-Hydroxy-propyl-4-methyl-furan-3-carboxylic acid amide .............. 44 4.2.4 4-Vinylphenol .......................................................................................... 50 4.2.5 2-Methoxy-4-vinylphenol ........................................................................ 51 4.3 Terrestrial Streptomyces sp. Ank 250 ...................................................... 52 4.3.1 2-(5-Chloro-2-hydroxy-phenyl)-benzoxazole-4-carboxylic acid methyl ester .........................................................................................................53 4.3.2 MC-033 .................................................................................................... 57 4.4 Terrestrial Streptomyces Strain GW 51/426 ............................................ 62 4.4.1 Dehydrorabelomycin-1-O--L-rhamnopyranoside ................................. 63 4.4.2 Rhodonocardin ......................................................................................... 68 4.4.3 Cyclo(Ala-Pro) ......................................................................................... 73 II Contents 4.5 Terrestrial Streptomyces sp. WO 463 ...................................................... 75 4.5.1 Oligomycin A ........................................................................................... 76 4.5.2 Oligomycin F ............................................................................................ 79 4.5.3 5'-Methoxy-6-(N,N-dimethyl)-adenosine ................................................ 83 4.5.4 4-α-L-Glucosyl--pyranone ..................................................................... 87 4.5.5 Other metabolites ..................................................................................... 90 4.6 Terrestrial Streptomyces sp. Ank 351 ...................................................... 91 4.6.1 Geldanamycin ........................................................................................... 92 4.6.2 17-O-Demethylgeldanamycin .................................................................. 96 4.6.3 Nigericin ................................................................................................... 99 4.6.4 11, 11'-O-Dimethylelaiophylin .............................................................. 102 4.6.5 11-O-Monomethylelaiophylin ................................................................ 107 4.6.6 Nocardamine .......................................................................................... 109 4.7 Terrestrial Streptomyces sp. Ank 202 .................................................... 110 4.7.1 Ravidomycin .......................................................................................... 111 4.7.2 N-(2-Methoxyphenyl)-acetamide ........................................................... 116 4.7.3 Phenazine-1-carboxylic acid .................................................................. 117 4.7.4 1-Carboxymethyl-phenazine .................................................................. 118 4.7.5 N6, N6-Dimethyladenosine .................................................................... 118 4.8 Terrestrial Streptomyces sp. Ank 291 .................................................... 119 4.8.1 Ditrisarubicin A ...................................................................................... 120 4.8.2 Ditrisarubicin B ...................................................................................... 122 4.8.3 A447 D' .................................................................................................. 123 4.9 Terrestrial Streptomyces sp. GW 13/475 ............................................... 127 4.9.1 3-Methoxy-streptenol C ......................................................................... 127 4.9.2 Streptenol A and C ................................................................................. 131 4.10 Terrestrial Streptomyces sp. GW 12/459 ............................................... 133 4.10.1 Bisphenol A diglycidyl ether (BADGE) ................................................ 134 4.10.2 3-Methoxy-1-[4-[1-methyl-1-[4-(2-oxiranylmethoxy)phenyl]ethyl]- phenoxy]- 2-propanol (BADGE∙OMe) .................................................. 139 4.10.3 3-Chloro-1-[4-[1-methyl-1-[4-(2-oxiranylmethoxy)phenyl]- ethyl]phenoxy]- 2-propanol (BADGE∙HCl) .......................................... 143 4.10.4 3-[4-[1-[4-(3-Chloro-2-hydroxypropoxy)phenyl]-1- methylethyl]phenoxy]-1,2-propanediol (BADGE∙HCl∙H2O) ................ 144 4.11 Terrestrial Streptomyces sp. GW 8594 .................................................. 147 4.11.1 3-Hexenyl-1-O--D-glycopyranoside .................................................... 149 4.11.2 3-Hexenyl-1-O--2'-methoxy-glycoside................................................ 151 Contents III 4.11.3 3-Hexenyl-1-O--D-glycoside ............................................................... 153 4.11.4 2-Phenylethanol-1-O--D-glucoside...................................................... 155 4.12 Terrestrial Streptomyces sp. Ank 282 .................................................... 157 4.12.1 Benadrostin ............................................................................................ 158 4.12.2 p-Hydroxybenzoic acid methyl ester ..................................................... 159 4.12.3 Macrolactin A......................................................................................... 160 5 Summary ............................................................................................... 162 6 Materials and Methods ........................................................................ 174 6.1 General ................................................................................................... 174 6.2 Materials ................................................................................................ 174 6.3 Spray Reagents ....................................................................................... 175 6.4 Microbiological Materials ...................................................................... 175 6.5 Recipes ..................................................................................................
Load more

Recommended publications
  • Actinobacterial Diversity of the Ethiopian Rift Valley Lakes
    ACTINOBACTERIAL DIVERSITY OF THE ETHIOPIAN RIFT VALLEY LAKES By Gerda Du Plessis Submitted in partial fulfillment of the requirements for the degree of Magister Scientiae (M.Sc.) in the Department of Biotechnology, University of the Western Cape Supervisor: Prof. D.A. Cowan Co-Supervisor: Dr. I.M. Tuffin November 2011 DECLARATION I declare that „The Actinobacterial diversity of the Ethiopian Rift Valley Lakes is my own work, that it has not been submitted for any degree or examination in any other university, and that all the sources I have used or quoted have been indicated and acknowledged by complete references. ------------------------------------------------- Gerda Du Plessis ii ABSTRACT The class Actinobacteria consists of a heterogeneous group of filamentous, Gram-positive bacteria that colonise most terrestrial and aquatic environments. The industrial and biotechnological importance of the secondary metabolites produced by members of this class has propelled it into the forefront of metagenomic studies. The Ethiopian Rift Valley lakes are characterized by several physical extremes, making it a polyextremophilic environment and a possible untapped source of novel actinobacterial species. The aims of the current study were to identify and compare the eubacterial diversity between three geographically divided soda lakes within the ERV focusing on the actinobacterial subpopulation. This was done by means of a culture-dependent (classical culturing) and culture-independent (DGGE and ARDRA) approach. The results indicate that the eubacterial 16S rRNA gene libraries were similar in composition with a predominance of α-Proteobacteria and Firmicutes in all three lakes. Conversely, the actinobacterial 16S rRNA gene libraries were significantly different and could be used to distinguish between sites.
    [Show full text]
  • Molecular and Immunological Sd0100025 Characterization of Mycobacteria Associated with Bovine Farcy
    MOLECULAR AND IMMUNOLOGICAL SD0100025 CHARACTERIZATION OF MYCOBACTERIA ASSOCIATED WITH BOVINE FARCY. Thesis submitted in accordance with requirements of the University of Khartoum for the Degree of Doctor of Philosophy (Ph.D). By Victor Loku Kwajok B.V.Med. 1978, University of Cairo/Egypt. M.V.Sc.1992, University of Khartoum/Sudan. Supervisor: Dr. Maowia M. Mukhtar. Institute of Endemic Diseases, University of Khartoum. Department of Preventive Medicine and Veterinary Public Health. Faculty of Veterinary Science, University of Khartoum. 2000. 32/27 SOME PAGES ARE MISSING IN THE ORIGINAL DOCUMENT LIST OF CONTENTS DEDICATION. * ii v ACKNOWLEDGEMENTS vi ABBREVIATIONS viii ABSTRACT. xi CHAPTER ONE. REVIEW OF LITERATURE. 1. General Introduction. 1. 1.1. Molecular Systematics of genus Mycobacterium. 2. 1.2. Molecular taxonomy of M. farcinogenese and M. senegalense 11. 1.3. Immunology of bovine farcy agents. 36. CHAPTER TWO. MATERIALS AND METHODOLOGY 41. Isolation, identification and characterization of M. farcinogenes. 2.1 Phenotypic characterization. 41. 2.1.1. Morphological and biochemical tests. 2.1.2. Degradation tests. 2.1.3. Rapid fluorogenic enzyme tests. 2.1.4. Nutritional tests. 2.1.5. Physiological tests. 2.2. Molecular characterization. 52. 2.2.1. DNA extraction and purification 2.2.2. PCR amplification and application. 2.2.3. DNA sequencing of 16SrDNA. 2.2.4. PCR-based restriction fragment length polymorphism. 2.3 Imrmmological analyses of bovine farcy agents. 71. 2.3.1 .EL1SA technique for sera diagnosis. 2.3.2 Animal pathogenicity Tests. 2.3.3 Protein antigen profiles determination using. CHAPTER THREE: RESULTS. 78. CHAPTER. FOUR: DISCUSSION. 124. REFERENCES. 133.
    [Show full text]
  • Systematic Research on Actinomycetes Selected According
    Systematic Research on Actinomycetes Selected according to Biological Activities Dissertation Submitted in fulfillment of the requirements for the award of the Doctor (Ph.D.) degree of the Math.-Nat. Fakultät of the Christian-Albrechts-Universität in Kiel By MSci. - Biol. Yi Jiang Leibniz-Institut für Meereswissenschaften, IFM-GEOMAR, Marine Mikrobiologie, Düsternbrooker Weg 20, D-24105 Kiel, Germany Supervised by Prof. Dr. Johannes F. Imhoff Kiel 2009 Referent: Prof. Dr. Johannes F. Imhoff Korreferent: ______________________ Tag der mündlichen Prüfung: Kiel, ____________ Zum Druck genehmigt: Kiel, _____________ Summary Content Chapter 1 Introduction 1 Chapter 2 Habitats, Isolation and Identification 24 Chapter 3 Streptomyces hainanensis sp. nov., a new member of the genus Streptomyces 38 Chapter 4 Actinomycetospora chiangmaiensis gen. nov., sp. nov., a new member of the family Pseudonocardiaceae 52 Chapter 5 A new member of the family Micromonosporaceae, Planosporangium flavogriseum gen nov., sp. nov. 67 Chapter 6 Promicromonospora flava sp. nov., isolated from sediment of the Baltic Sea 87 Chapter 7 Discussion 99 Appendix a Resume, Publication list and Patent 115 Appendix b Medium list 122 Appendix c Abbreviations 126 Appendix d Poster (2007 VAAM, Germany) 127 Appendix e List of research strains 128 Acknowledgements 134 Erklärung 136 Summary Actinomycetes (Actinobacteria) are the group of bacteria producing most of the bioactive metabolites. Approx. 100 out of 150 antibiotics used in human therapy and agriculture are produced by actinomycetes. Finding novel leader compounds from actinomycetes is still one of the promising approaches to develop new pharmaceuticals. The aim of this study was to find new species and genera of actinomycetes as the basis for the discovery of new leader compounds for pharmaceuticals.
    [Show full text]
  • Actinobacterial Diversity in Atacama Desert Habitats As a Road Map to Biodiscovery
    Actinobacterial Diversity in Atacama Desert Habitats as a Road Map to Biodiscovery A thesis submitted by Hamidah Idris for the award of Doctor of Philosophy July 2016 School of Biology, Faculty of Science, Agriculture and Engineering, Newcastle University, Newcastle Upon Tyne, United Kingdom Abstract The Atacama Desert of Northern Chile, the oldest and driest nonpolar desert on the planet, is known to harbour previously undiscovered actinobacterial taxa with the capacity to synthesize novel natural products. In the present study, culture-dependent and culture- independent methods were used to further our understanding of the extent of actinobacterial diversity in Atacama Desert habitats. The culture-dependent studies focused on the selective isolation, screening and dereplication of actinobacteria from high altitude soils from Cerro Chajnantor. Several strains, notably isolates designated H9 and H45, were found to produce new specialized metabolites. Isolate H45 synthesized six novel metabolites, lentzeosides A-F, some of which inhibited HIV-1 integrase activity. Polyphasic taxonomic studies on isolates H45 and H9 showed that they represented new species of the genera Lentzea and Streptomyces, respectively; it is proposed that these strains be designated as Lentzea chajnantorensis sp. nov. and Streptomyces aridus sp. nov.. Additional isolates from sampling sites on Cerro Chajnantor were considered to be nuclei of novel species of Actinomadura, Amycolatopsis, Cryptosporangium and Pseudonocardia. A majority of the isolates produced bioactive compounds that inhibited the growth of one or more strains from a panel of six wild type microorganisms while those screened against Bacillus subtilis reporter strains inhibited sporulation and cell envelope, cell wall, DNA and fatty acid synthesis.
    [Show full text]
  • Phd Template
    NATIONAL TECHNICAL UNIVERSITY OF ATHENS SCHOOL OF CHEMICAL ENGINEERING DEPARTMENT OF SYNTHESIS AND DEVELOPMENT OF INDUSTRIAL PROCESSES BIOTECHNOLOGY LABORATORY ISOLATION AND IDENTIFICATION OF METABOLITES FROM MARINE-DERIVED ACTINOBACTERIA DOCTORAL THESIS ENIKO RAB ATHENS DECEMBER 2018 ADVISORY COMMITTEE Dimitrios Kekos (Supervisor) Professor, School of Chemical Engineering, National Technical University of Athens Vassilios Roussis Professor, Department of Pharmacy, National and Kapodistrian University of Athens Efstathia Ioannou Assist. Professor, Department of Pharmacy, National and Kapodistrian University of Athens EXAMINATION COMMITTEE Dimitrios Kekos Professor, School of Chemical Engineering, National Technical University of Athens Vassilios Roussis Professor, Department of Pharmacy, National and Kapodistrian University of Athens Olga Tzakou Professor, Department of Pharmacy, National and Kapodistrian University of Athens Maria Couladis Assoc. Professor, Department of Pharmacy, National and Kapodistrian University of Athens Anastasia Detsi Assoc. Professor, School of Chemical Engineering, National Technical University of Athens Efstathia Ioannou Assist. Professor, Department of Pharmacy, National and Kapodistrian University of Athens Evangelos Topakas Assist. Professor, School of Chemical Engineering, National Technical University of Athens ABSTRACT Intensive studies of mainly soil-derived bacteria and fungi have shown that microorganisms are a rich source of structurally unique and pharmaceutically important bioactive substances.
    [Show full text]
  • Chapter One Introduction and Objectives
    CHAPTER ONE INTRODUCTION AND OBJECTIVES 1 CHAPTER ONE 1.1. INTRODUCTION Resistance by pathogenic bacteria has become a major health concern. Many Gram-positive bacteria and Gram-negative opportunistic pathogens were becoming resistant to virtually every clinically available drug. The emergence of multi resistant pathogenic strains has caused a therapeutic problem of enormous proportions. For instance, they cause substantial morbidity and mortality especially among the elderly and immunocompromised patients. In response, there is a renewed interest in discovering novel classes of antibiotics that have different mechanisms of action (Ogunmwonyi, 2010). Natural products have been regarded as important sources of antimicrobial compounds. There are great potential in bio-prospecting from the sea and marine natural products research has just started to bloom (Kiruthika et al., 2013). Marine microorganisms have become an important source of novel microbial products (Haggag et al., 2014). Thus, the interest of investigators was directed towards marine habitat as unusual source to be explored for the development of new drugs. Significant part of this attention has been paid to marine microorganisms, which have become important in the study of novel compounds exhibiting antibacterial, antifungal, and antitumor (Kokare et al., 2004). The dramatic increase in the prevalence of human pathogens resistant to most known antibiotics, and the emergence of new pathogens, stimulated the search for novel and potent antibiotics. Microorganisms in marine attract a great deal of attention, due to their adaptability to extreme environments. This allows the 2 organisms to produce different types of bioactive compounds including antibiotics with unique properties and applications (Mohan et al., 2013). In the last decades members of Actinomycetes became almost the most important source for antibiotics.
    [Show full text]